To explore the effects of increased expression of Bcl-XL on TRAIL-induced responses, several human breast tumour cell lines were examined for the expression levels of Bcl-2 and Bcl-XL, and their sensitivities to TRAIL (data not shown). The gene discussed is TNFSF10; the disease is breast neoplasm.